Skip to main content

Table 5 Effects of CTS on FFA, MDA, GSH and ATPase in the livers of mice fed with HFD

From: Crude triterpenoid saponins from Ilex latifolia (Da Ye Dong Qing) ameliorate lipid accumulation by inhibiting SREBP expression via activation of AMPK in a non-alcoholic fatty liver disease model

Parameter

Control

HFD

HFD + Simvastatin

HFD + CTS-100

HFD + CTS-200

FFA (μmol/g protein)

61.05 Â± 12.49

94.70 Â± 15.63##

91.73 Â± 13.50â–³

93.89 Â± 10.81*

79.87 Â± 11.18**

MDA (nmol/mg protein)

0.69 Â± 0.34

3.19 Â± 0.33##

1.88 Â± 0.44△△

1.68 Â± 0.54**

1.50 Â± 0.38**

GSH (μg/mg protein)

2.65 Â± 0.53

1.05 Â± 0.24##

2.80 Â± 0.59△△

2.55 Â± 0.65**

2.61 Â± 0.50**

Na+-K+-ATPase (mmol pi/g/h)

1.55 Â± 0.19

1.79 Â± 018#

1.57 Â± 0.26â–³

1.68 Â± 0.10

1.60 Â± 0.26*

Ca2+-Mg2+-ATPase (mmol pi/g/h)

1.65 Â± 0.13

1.76 Â± 0.11#

1.31 Â± 0.14â–³

1.55 Â± 0.14**

1.42 Â± 0.31**

  1. Values were expressed as the mean Â± SD (n = 10). # P < 0.05, ## P < 0.01, HFD vs. control. â–³ P < 0.05, △△ P < 0.01, HFD vs. simvastatin treatment. *P < 0.05, **P < 0.01, HFD vs. CTS treatment.